WisdomTree BioRevolution Fund Rating $22.33 -0.46 (-2.02%) As of 10:22 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatings WisdomTree BioRevolution Fund Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.WDNA Aggregate RatingModerate Buy 2.65Holdings in WDNA have an aggregate rating of Moderate Buy based on 445 analyst ratings issued in the past year covering 23 companies (49.2% of the portfolio).WDNA Aggregate Price Target$22.33High Prediction$22.33Average Prediction$22.33Low Prediction$22.33Holdings in WDNA have an aggregate price target of $22.33 and a range of $22.33 to $22.33 covering 23 companies (49.2% of the portfolio).WDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by WisdomTree BioRevolution Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 WDNA Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings3.74%TEMTempus AI$69.82-8.0%Hold$79.37 13.7%222.801 of 5 stars3.64%LLYEli Lilly and Company$1,439.15+0.8%Moderate Buy$1,416.64 -1.6%303.9616 of 5 starsTrending NewsAnalyst Downgrade3.38%MRNAModerna$227.45-1.7%Hold$113.75 -50.0%251.6966 of 5 starsTrending NewsEarnings ReportAnalyst RevisionGap Down3.00%TWSTTwist Bioscience$111.80-2.1%Hold$145.00 29.7%123.0474 of 5 starsTrending NewsEarnings ReportAnalyst ForecastGap Down2.92%IMNMImmunome$18.60-0.5%Moderate Buy$33.85 82.0%162.5341 of 5 starsTrending NewsEarnings ReportAnalyst ForecastAnalyst Revision2.56%TMOThermo Fisher Scientific$697.39-0.3%Moderate Buy$683.64 -2.0%293.6822 of 5 starsPositive News2.38%NTRANatera$316.18-2.1%Moderate Buy$394.31 24.7%233.3434 of 5 stars2.33%STOKStoke Therapeutics$26.42+0.8%Moderate Buy$44.17 67.2%112.0746 of 5 stars2.14%UTHRUnited Therapeutics$592.00-0.2%Moderate Buy$676.40 14.3%164.6178 of 5 starsInsider TradeAnalyst Revision1.92%TXG10x Genomics$57.76-2.3%Hold$68.40 18.4%182.6925 of 5 stars1.90%VRTXVertex Pharmaceuticals$538.20-0.8%Moderate Buy$596.44 10.8%283.4395 of 5 stars1.81%GILDGilead Sciences$168.56+0.4%Moderate Buy$171.07 1.5%293.4253 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision1.81%AMGNAmgen$466.19-0.2%Hold$424.66 -8.9%334.0602 of 5 starsTrending NewsAnalyst Forecast1.78%CGONCG Oncology$71.30+1.6%Moderate Buy$88.11 23.6%111.7754 of 5 starsEarnings ReportAnalyst Revision1.75%ROIVRoivant Sciences$39.41-1.4%Moderate Buy$46.64 18.3%142.0412 of 5 starsTrending NewsAnalyst ForecastInsider Trade1.68%RVMDRevolution Medicines$171.08-3.0%Moderate Buy$263.15 53.8%243.6097 of 5 starsAnalyst Revision1.55%DARDarling Ingredients$55.38+0.0%Moderate Buy$73.80 33.3%124.542 of 5 stars1.53%CRSPCRISPR Therapeutics$42.41-0.5%Moderate Buy$72.93 72.0%172.9416 of 5 starsAnalyst Forecast1.50%PFEPfizer$28.72-0.4%Hold$30.32 5.6%222.8544 of 5 starsTrending NewsAnalyst Forecast1.49%VYLRVylor$72.38+0.4%Moderate Buy$82.50 14.0%153.8692 of 5 starsNews CoverageEarnings Report1.47%BEAMBeam Therapeutics$23.46-2.4%Moderate Buy$47.64 103.0%132.7712 of 5 starsAnalyst ForecastAnalyst Revision1.45%XNCRXencor$37.70-1.1%Moderate Buy$42.22 12.0%111.798 of 5 starsInsider Trade1.42%KRYSKrystal Biotech$304.17-0.5%Moderate Buy$375.00 23.3%143.386 of 5 stars This page (BATS:WDNA) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredTrump, Schiff and Dalio all point to the same warning signIn 1929, the Dow fell 89 percent and took 25 years to recover. A 60-year-old who held on wasn't made whole unt...USA Capital Gold | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WisdomTree BioRevolution Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share WisdomTree BioRevolution Fund With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free WDNA Stock Alerts